Experience

Blue Matter

• United States
• Business Consulting and Services
• 100 - 200 Employee

• Associate Principal

  • Mar 2022 - Present

  New York, United States Lead life science strategy engagements to help clients solve critical problems in the biotech and pharmaceutical space; focus in Medical and Commercial Strategy, Launch Excellence, Rare Disease and Oncology. Selected experience: - Commercialization strategy and roadmap development, customizing recommended pre-launch activities and timing to best match brand and corporate strategic priorities (multiple engagements spanning first and subsequent launches / Alliance launches / "early" start… Show more Lead life science strategy engagements to help clients solve critical problems in the biotech and pharmaceutical space; focus in Medical and Commercial Strategy, Launch Excellence, Rare Disease and Oncology. Selected experience: - Commercialization strategy and roadmap development, customizing recommended pre-launch activities and timing to best match brand and corporate strategic priorities (multiple engagements spanning first and subsequent launches / Alliance launches / "early" start vs final 18 months) - Medical Affairs Strategy and integrated plan for Alliance product launch across multiple concurrent indications - In-person multi-day competitive strategy workshop for global leadership of a leading heme-onc brand - Design of "Incubator" partnership between global pharma and leading university, incl. market research-based validation and feasibility assessment - Post-launch insight generation and strategy refinement for first-to-market Rare Disease product

• Consulting Manager

  • Sep 2020 - Mar 2022

  New York, United States Manage engagements in brand, commercial and franchise strategy, launch planning across life sciences. Focus in oncology and rare disease. Selected experience: - Early commercialization strategy and positioning for gene therapy assets in pediatric Rare Disease - US and Global Brand Strategy for heme-onc product in a competitive space - Virtual, multi-day global workshop planning for a pre-launch asset - Launch Strategy and Launch planning for first asset in an orphan indication… Show more Manage engagements in brand, commercial and franchise strategy, launch planning across life sciences. Focus in oncology and rare disease. Selected experience: - Early commercialization strategy and positioning for gene therapy assets in pediatric Rare Disease - US and Global Brand Strategy for heme-onc product in a competitive space - Virtual, multi-day global workshop planning for a pre-launch asset - Launch Strategy and Launch planning for first asset in an orphan indication (US & EU)

• Senior Consultant

  • Sep 2019 - Aug 2020

  Greater New York City Area



IQVIA

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Consultant, Associate Consultant

  • Jul 2017 - Aug 2019

  Greater New York City Area Responsible for project design, management and execution for engagements spanning the healthcare space, with a focus on commercial strategy & rare disease Highlighted projects include: - Medical launch plan roadmap and real world evidence strategy development for an ex-US pharmaco launching their first US product into an orphan disease space - Strategic plan development and data asset opportunity assessment for a leading oncology non-profit - Multi-market opportunity assessment… Show more Responsible for project design, management and execution for engagements spanning the healthcare space, with a focus on commercial strategy & rare disease Highlighted projects include: - Medical launch plan roadmap and real world evidence strategy development for an ex-US pharmaco launching their first US product into an orphan disease space - Strategic plan development and data asset opportunity assessment for a leading oncology non-profit - Multi-market opportunity assessment for the first product launching for a rare neuromuscular disease - Comprehensive market landscape, gap analysis and business development strategy development for a life science biotech in an immature, rapidly evolving market - Landmark report of neuromuscular disease care, pipeline, costs and future challenges & opportunities for a leading nonprofit focused on patient advocacy Show less



Weill Cornell Medicine

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Doctoral Candidate

  • Sep 2011 - May 2017

  Laboratory of Dr. Todd Evans Leveraged genome editing and molecular biology techniques to characterize downstream targets of the transcription factor GATA4 in the development, maintenance and stress response of the heart, and reciprocal compensation between GATA4 and GATA6 in the developing embryo. Model systems included zebrafish, immortalized cardiac cell lines and human stem cell-derived cardiomyocytes as complimentary systems to illuminate developmental roles, cellular function and biochemical properties of… Show more Leveraged genome editing and molecular biology techniques to characterize downstream targets of the transcription factor GATA4 in the development, maintenance and stress response of the heart, and reciprocal compensation between GATA4 and GATA6 in the developing embryo. Model systems included zebrafish, immortalized cardiac cell lines and human stem cell-derived cardiomyocytes as complimentary systems to illuminate developmental roles, cellular function and biochemical properties of genes of interest. Show less